Amneal Makes First Biosimilar Launch With US Bevacizumab

Alymsys Rival To Avastin, Developed By mAbxience, Is Introduced In US

 
• By David Wallace
  
Amneal HQ building sign
Amneal has launched its first biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products